The purpose of this study is to investigate the following about donepezil hydrochloride administration in patients with mild or moderate Alzheimer's Disease in clinical practice: cognitive function, Functional Assessment Staging (FAST) score, adverse events/adverse drug reactions, and patient background.
Study Type
OBSERVATIONAL
Enrollment
10,238
This is a multicenter, open-labeled, practice-based, post-marketing surveillance study. Therefore, dosing is not specified.
The transition of clinical condition is evaluated comparing the result of HDS-R,MMSE with the time of study initiation
Time frame: 48 months(12 weeks and every 6 months)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Unnamed facility
Aisai, Aichi-ken, Japan
Unnamed facility
Chita, Aichi-ken, Japan
Unnamed facility
Gamagōri, Aichi-ken, Japan
Unnamed facility
Handa, Aichi-ken, Japan
Unnamed facility
Ichinomiya, Aichi-ken, Japan
Unnamed facility
Inazawa, Aichi-ken, Japan
Unnamed facility
Inuyama, Aichi-ken, Japan
Unnamed facility
Kariya, Aichi-ken, Japan
Unnamed facility
Kasugai, Aichi-ken, Japan
Unnamed facility
Komaki, Aichi-ken, Japan
...and 712 more locations